DW
Dianne C. Whitfield
Chief Human Resources Officer

Dianne C. Whitfield insider trades: Tarsus Pharmaceuticals (TARS) stock sales

Chief Human Resources Officer, Tarsus Pharmaceuticals Last trade Jan 2, 2026 18 Form 4 filings
$1.8M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Dianne reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 2, 2026TARS↓ Sell$1.3M
Dec 16, 2025TARS↓ Sell$592K
Mar 20, 2025TARS↓ Sell$321K
Mar 18, 2024TARS↓ Sell$132K
Nov 30, 2023TARS↓ Sell$136K
Mar 23, 2023TARS↓ Sell$13K
Mar 20, 2023TARS↓ Sell$8K
Mar 16, 2023TARS↓ Sell$4K
Dec 2, 2022TARS↓ Sell$20K
Dec 1, 2022TARS↓ Sell$39K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TARS insiders

Open-market trades in the last 12 months

About Dianne C. Whitfield's insider trades

Dianne C. Whitfield is Chief Human Resources Officer at Tarsus Pharmaceuticals (TARS). Since Dec 1, 2022, Dianne has reported no open-market purchases and 10 sales worth $2.5M on SEC Form 4. In the last 12 months: 2 sales ($1.8M).

Their filings also include option exercises (6 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TARS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.